{"paper_id":"8b0609c8-9e50-498f-bf02-f47be7facd50","body_text":"腹腔液白介素-6、转化生长因子-β和基质金属蛋白酶-7与子宫内膜异位症的相关研究\nRelationship of IL-6 ,TGF-β,matrix metalloproteinase-7 in peritoneal fluid and endometriosis\n摘要目的 探讨腹腔液中白细胞介素-6 (IL-6)、转化生长因子-β(TGF-β)和基质金属蛋白酶-7(MMP-7)在不同r-AFS分期的子宫内膜异位症(EMs)患者腹腔液中的表达.方法 收集80例行腹腔镜检查及治疗的患者腹腔液,其中35例为无子宫内膜异位症的对照组,36例为子宫内膜异位症Ⅰ、Ⅱ期患者,9例为子宫内膜异位症Ⅲ、Ⅳ期的患者.采用双抗体夹心酶联免疫吸附(ELISA)法检测腹腔液中IL-6、TGF-β和MMP-9的浓度,并进行相关性分析.结果 子宫内膜异位症患者腹腔液中IL-6、TGF-β和MMP-7表达分别为(736.5±526.6) ng/L、(936.5±523.5) ng/L和(5.63±1.98) μg/L,明显高于对照组,差异均有统计学意义(均P＜0.01).子宫内膜异位症Ⅲ、Ⅳ期IL-6和MMP-7浓度分别为(948.6±485.4) ng/L、(8.69±1.23) μg/L,高于Ⅰ、Ⅱ期(453.6±256.8) ng/L、(4.23±1.08) μg/L,差异有统计学意义(均P＜0.05).IL-6与MMP-7的表达呈显著正相关(r =0.789,P＜0.01).TGF-β与MMP-7的表达呈显著负相关(r=-0.458,P＜0.05).结论 子宫内膜异位症患者腹腔液中IL-6、TGF-β、MMP-7可能导致腹腔微环境免疫失衡,并对子宫内膜异位症的发生发展起一定的促进作用.\n更多相关知识\nabstractsObjective To evaluate the expression of IL-6,TGF-β,matrix metalloproteinase-7 (MMP-7) in the peritoneal fluid of different stage of endometriosis (EMs) patients.Methods Peritoneal fluid samples from female without EMs (n =35) and 45 patients with EMs (36 cases with stage Ⅰ,Ⅱ;9 cases with stage Ⅲ,Ⅳ)were obtained for detectionof IL-6,TGF-β,MMP-7byELISA.Results TheconcentrationofIL-6,TGF-β,MMP-7 was (736.5 ± 526.6) ng/L,(936.5 ± 523.5)ng/L and (5.63 ± 1.98) μg/L in EMs patients,which were higher than those in control group (P ＜ 0.01).The concentration of IL-6,MMP-7 was (948.6 ± 485.4) ng/L,(8.69 ± 1.23) μg/L in stage Ⅲ,Ⅳgroup,and (453.6 ± 256.8) rng/L,(4.23 ± 1.08) μg/L in stage Ⅰ,Ⅱ group,there were significant differences between the two groups (P ＜ 0.05).The concentration of MMP-7 was positively correlated with IL-6(r =0.789,P ＜0.01),and was negatively correlated with TGF-β(r =-0.458,P ＜0.05).Conclusion IL-6,TGF-β,MMP-7 may play roles in microecology immune imbalance and the development of EMs.\nMore相关知识\n- 浏览0\n- 被引4\n- 下载0\n相似文献\n- 中文期刊\n- 外文期刊\n- 学位论文\n- 会议论文","source_license":"CC0","license_restricted":false}